VBI Vaccines
VBIV
#10030
Rank
A$2.9 M
Marketcap
$0.10
Share price
0.00%
Change (1 day)
-90.07%
Change (1 year)

Earnings for VBI Vaccines (VBIV)

Earnings in 2024 (TTM): -A$0.13 Billion

According to VBI Vaccines 's latest financial reports the company's current earnings are A$9.41 Million. In 2023 the company made an earning of -A$0.15 Billion, an increase over its 2022 earnings that were of -A$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for VBI Vaccines from 1998 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.13 Billion-11.89%
2023 -A$0.15 Billion-18.06%
2022 -A$0.18 Billion62.43%
2021 -A$0.11 Billion50.88%
2020 -A$71.62 Million-15.66%
2019 -A$84.92 Million-13.82%
2018 -A$98.53 Million61.32%
2017 -A$61.08 Million57.8%
2016 -A$38.71 Million-67.39%
2015 -A$0.12 Billion1527.36%
2014 -A$7.3 Million36.21%
2013 -A$5.36 Million-63.91%
2012 -A$14.84 Million-59.19%
2011 -A$36.37 Million227.23%
2010 -A$11.12 Million1741.53%
2009 -A$0.61 Million14.52%
2008 -A$0.53 Million-42.93%
2007 -A$0.93 Million21.8%
2006 -A$0.76 Million172.39%
2005 -A$0.28 Million115.38%
2004 -A$0.13 Million-42.27%
2003 -A$0.23 Million109.27%
2002 -A$0.11 Million17.89%
2001 -A$0.1 Million-369.64%
2000 A$0.03 M-69.24%
1999 A$0.1 M12.77%
1998 A$0.09 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$28.13 Million-78.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.24 Billion 84.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$72.21 Million-43.83%๐Ÿ‡บ๐Ÿ‡ธ USA